All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Oral Bioavailability Innovations

 It is the amount of the complete dosage that actually reaches to the circulatory system or blood stream, but it does not all reach the bloodstream at once, so one cannot basically take a blood sample, find out how much drug is in it and separate that quantity by the dose. It is quite totally defined when used accurately. The strategies for enhancing the oral bioavailability of drugs are (i) solid dispersions (ii) self-emulsifying drug delivery systems (SEDDS/SMEDDS) technologies. Both technologies are widely used in the industry today. Oral bioavailability innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks into” the market or society.